Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)

NCT: NCT06806709 · RECRUITING

NCT IDNCT06806709
StatusRECRUITING
Start Date2025-08-18
Completion2026-12-31
SponsorThe University of Queensland (OTHER)
First posted
Last updated

Brief Summary

Blood cultures (BCs) are a blood test to look for an infection. Two problems with the sample collection are contamination by germs outside of the blood and not collecting enough blood in the tube, resulting in unusable samples. Many patients requiring a BC also have a peripheral intravenous catheter ("catheter") but these are not normally used for blood sampling. This means that patients receive many painful needles for both catheter insertion and blood sampling. There is a needle-free blood collection device (PIVO Pro) which can be used with a catheter to collect a blood sample. The goal of the PIVO Trial is to see if using the PIVO Pro for blood culture sample collection will have a lower amount of contamination than the usual method of blood sample collection. Patients 18 and older at 3 emergency departments will be included. Research nurses will look for patients in emergency who need a blood culture sample taken and they will be asked if they want to be involved in the trial. Half of the participants will use the PIVO Pro to take their blood sample and half will have the usual way of collecting blood. Participants do not have to do anything specifically for the trial. Information about the blood collection and results of the blood culture will be collected from the medical records and recorded for the trial.

Frequently Asked Questions

What is Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)?

Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial) is a clinical trial registered under NCT06806709. Current status: RECRUITING.

What is the status of NCT06806709?

The current status of NCT06806709 (Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial)) is: RECRUITING.

When did Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial) start?

Reducing Blood Culture Contamination With the Use of a Needle-less Blood Draw Device (The PIVO Trial) started on 2025-08-18.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.